Page last updated: 2024-09-05

zm 241385 and butaclamol

zm 241385 has been researched along with butaclamol in 1 studies

Compound Research Comparison

Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010)
(zm 241385)
Studies
(butaclamol)
Trials
(butaclamol)
Recent Studies (post-2010) (butaclamol)
40131243308

Protein Interaction Comparison

ProteinTaxonomyzm 241385 (IC50)butaclamol (IC50)
D(2) dopamine receptorHomo sapiens (human)0.0123
DRattus norvegicus (Norway rat)0.002
D(3) dopamine receptorRattus norvegicus (Norway rat)0.002
D(1A) dopamine receptorHomo sapiens (human)0.05
D(4) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.002
D(4) dopamine receptorRattus norvegicus (Norway rat)0.002
D(3) dopamine receptorHomo sapiens (human)0.0139
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0053
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0525

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO1

Other Studies

1 other study(ies) available for zm 241385 and butaclamol

ArticleYear
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Journal of medicinal chemistry, 2005, Nov-03, Volume: 48, Issue:22

    Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles

2005